{"id":9902,"date":"2019-02-07T14:13:14","date_gmt":"2019-02-07T13:13:14","guid":{"rendered":"https:\/\/udic.es\/?p=9902"},"modified":"2019-09-10T12:04:11","modified_gmt":"2019-09-10T10:04:11","slug":"new-phase-i-clinical-trial-in-early-parkinsons","status":"publish","type":"post","link":"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/","title":{"rendered":"New phase I clinical trial in early Parkinson&#8217;s."},"content":{"rendered":"<p class=\"p1\"><span class=\"s1\">Our clinical trials unit will start a new phase I trial in patients with early Parkinson&#8217;s disease. Patients will be included in different cohorts, single dose and ascending doses, in patients with or without mutations in the LRRK2 gene, by means of an intrathecal administration of an antisense oligonucleotide. Only 62 patients will participate in 17 centers in different countries, including our site, Hospital Universitari General de Catalunya.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Our clinical trials unit will start a new phase I trial in patients with early Parkinson&#8217;s disease. Patients will be included in different cohorts, single dose and ascending doses, in patients with or without mutations in the LRRK2 gene, by means of an intrathecal administration of an antisense oligonucleotide. Only 62 patients will participate in&#8230;<\/p>\n","protected":false},"author":2,"featured_media":9331,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[130,1],"tags":[],"class_list":["post-9902","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-parkinson-en","category-uncategorised"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>New phase I clinical trial in early Parkinson&#039;s. - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica<\/title>\n<meta name=\"description\" content=\"Our clinical trials unit will start a new phase I trial in patients with early Parkinson&#039;s disease. Patients will be included in different cohorts, single\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New phase I clinical trial in early Parkinson&#039;s. - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\" \/>\n<meta property=\"og:description\" content=\"Our clinical trials unit will start a new phase I trial in patients with early Parkinson&#039;s disease. Patients will be included in different cohorts, single\" \/>\n<meta property=\"og:url\" content=\"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/\" \/>\n<meta property=\"og:site_name\" content=\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci%c3%b3-Cl%c3%adnica-447149502490430\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-02-07T13:13:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-09-10T10:04:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"5056\" \/>\n\t<meta property=\"og:image:height\" content=\"1752\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tito Surribas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tito Surribas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/\"},\"author\":{\"name\":\"Tito Surribas\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/a8ae8ae960ad58f89663d1d0a2199d1e\"},\"headline\":\"New phase I clinical trial in early Parkinson&#8217;s.\",\"datePublished\":\"2019-02-07T13:13:14+00:00\",\"dateModified\":\"2019-09-10T10:04:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/\"},\"wordCount\":74,\"publisher\":{\"@id\":\"https:\/\/udic.es\/#organization\"},\"image\":{\"@id\":\"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1-1.jpg\",\"articleSection\":[\"Parkinson\",\"Uncategorised\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/\",\"url\":\"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/\",\"name\":\"New phase I clinical trial in early Parkinson's. - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\",\"isPartOf\":{\"@id\":\"https:\/\/udic.es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1-1.jpg\",\"datePublished\":\"2019-02-07T13:13:14+00:00\",\"dateModified\":\"2019-09-10T10:04:11+00:00\",\"description\":\"Our clinical trials unit will start a new phase I trial in patients with early Parkinson's disease. Patients will be included in different cohorts, single\",\"breadcrumb\":{\"@id\":\"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/#primaryimage\",\"url\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1-1.jpg\",\"contentUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1-1.jpg\",\"width\":5056,\"height\":1752,\"caption\":\"Proyectos1 1\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/udic.es\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New phase I clinical trial in early Parkinson&#8217;s.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/udic.es\/#website\",\"url\":\"https:\/\/udic.es\/\",\"name\":\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\",\"description\":\"Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\",\"publisher\":{\"@id\":\"https:\/\/udic.es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/udic.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/udic.es\/#organization\",\"name\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"url\":\"https:\/\/udic.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/udic.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png\",\"contentUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png\",\"width\":408,\"height\":123,\"caption\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\"},\"image\":{\"@id\":\"https:\/\/udic.es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci\u00f3-Cl\u00ednica-447149502490430\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/a8ae8ae960ad58f89663d1d0a2199d1e\",\"name\":\"Tito Surribas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ae5f603516ade2643999845ead05442c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ae5f603516ade2643999845ead05442c?s=96&d=mm&r=g\",\"caption\":\"Tito Surribas\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New phase I clinical trial in early Parkinson's. - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","description":"Our clinical trials unit will start a new phase I trial in patients with early Parkinson's disease. Patients will be included in different cohorts, single","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/","og_locale":"en_US","og_type":"article","og_title":"New phase I clinical trial in early Parkinson's. - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","og_description":"Our clinical trials unit will start a new phase I trial in patients with early Parkinson's disease. Patients will be included in different cohorts, single","og_url":"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/","og_site_name":"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","article_publisher":"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci%c3%b3-Cl%c3%adnica-447149502490430\/","article_published_time":"2019-02-07T13:13:14+00:00","article_modified_time":"2019-09-10T10:04:11+00:00","og_image":[{"width":5056,"height":1752,"url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1-1.jpg","type":"image\/jpeg"}],"author":"Tito Surribas","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tito Surribas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/#article","isPartOf":{"@id":"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/"},"author":{"name":"Tito Surribas","@id":"https:\/\/udic.es\/#\/schema\/person\/a8ae8ae960ad58f89663d1d0a2199d1e"},"headline":"New phase I clinical trial in early Parkinson&#8217;s.","datePublished":"2019-02-07T13:13:14+00:00","dateModified":"2019-09-10T10:04:11+00:00","mainEntityOfPage":{"@id":"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/"},"wordCount":74,"publisher":{"@id":"https:\/\/udic.es\/#organization"},"image":{"@id":"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/#primaryimage"},"thumbnailUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1-1.jpg","articleSection":["Parkinson","Uncategorised"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/","url":"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/","name":"New phase I clinical trial in early Parkinson's. - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","isPartOf":{"@id":"https:\/\/udic.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/#primaryimage"},"image":{"@id":"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/#primaryimage"},"thumbnailUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1-1.jpg","datePublished":"2019-02-07T13:13:14+00:00","dateModified":"2019-09-10T10:04:11+00:00","description":"Our clinical trials unit will start a new phase I trial in patients with early Parkinson's disease. Patients will be included in different cohorts, single","breadcrumb":{"@id":"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/#primaryimage","url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1-1.jpg","contentUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1-1.jpg","width":5056,"height":1752,"caption":"Proyectos1 1"},{"@type":"BreadcrumbList","@id":"https:\/\/udic.es\/en\/new-phase-i-clinical-trial-in-early-parkinsons\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/udic.es\/en\/"},{"@type":"ListItem","position":2,"name":"New phase I clinical trial in early Parkinson&#8217;s."}]},{"@type":"WebSite","@id":"https:\/\/udic.es\/#website","url":"https:\/\/udic.es\/","name":"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","description":"Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","publisher":{"@id":"https:\/\/udic.es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/udic.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/udic.es\/#organization","name":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","url":"https:\/\/udic.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/udic.es\/#\/schema\/logo\/image\/","url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png","contentUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png","width":408,"height":123,"caption":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica"},"image":{"@id":"https:\/\/udic.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci\u00f3-Cl\u00ednica-447149502490430\/"]},{"@type":"Person","@id":"https:\/\/udic.es\/#\/schema\/person\/a8ae8ae960ad58f89663d1d0a2199d1e","name":"Tito Surribas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/udic.es\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ae5f603516ade2643999845ead05442c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ae5f603516ade2643999845ead05442c?s=96&d=mm&r=g","caption":"Tito Surribas"}}]}},"_links":{"self":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/posts\/9902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/comments?post=9902"}],"version-history":[{"count":2,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/posts\/9902\/revisions"}],"predecessor-version":[{"id":10244,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/posts\/9902\/revisions\/10244"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/media\/9331"}],"wp:attachment":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/media?parent=9902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/categories?post=9902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/tags?post=9902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}